These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33187827)

  • 41. DPM2-CDG: a muscular dystrophy-dystroglycanopathy syndrome with severe epilepsy.
    Barone R; Aiello C; Race V; Morava E; Foulquier F; Riemersma M; Passarelli C; Concolino D; Carella M; Santorelli F; Vleugels W; Mercuri E; Garozzo D; Sturiale L; Messina S; Jaeken J; Fiumara A; Wevers RA; Bertini E; Matthijs G; Lefeber DJ
    Ann Neurol; 2012 Oct; 72(4):550-8. PubMed ID: 23109149
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mutations in COG2 encoding a subunit of the conserved oligomeric golgi complex cause a congenital disorder of glycosylation.
    Kodera H; Ando N; Yuasa I; Wada Y; Tsurusaki Y; Nakashima M; Miyake N; Saitoh S; Matsumoto N; Saitsu H
    Clin Genet; 2015 May; 87(5):455-60. PubMed ID: 24784932
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular diagnostic testing for congenital disorders of glycosylation (CDG): detection rate for single gene testing and next generation sequencing panel testing.
    Jones MA; Rhodenizer D; da Silva C; Huff IJ; Keong L; Bean LJ; Coffee B; Collins C; Tanner AK; He M; Hegde MR
    Mol Genet Metab; 2013; 110(1-2):78-85. PubMed ID: 23806237
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Abnormal expression of lysosomal glycoproteins in patients with congenital disorders of glycosylation.
    Sabry S; Eissa NR; Zaki MS
    BMC Res Notes; 2023 Apr; 16(1):53. PubMed ID: 37069668
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical, biochemical and molecular phenotype of congenital disorders of glycosylation: long-term follow-up.
    Bogdańska A; Lipiński P; Szymańska-Rożek P; Jezela-Stanek A; Rokicki D; Socha P; Tylki-Szymańska A
    Orphanet J Rare Dis; 2021 Jan; 16(1):17. PubMed ID: 33407696
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CDG-IL: an infant with a novel mutation in the ALG9 gene and additional phenotypic features.
    Weinstein M; Schollen E; Matthijs G; Neupert C; Hennet T; Grubenmann CE; Frank CG; Aebi M; Clarke JT; Griffiths A; Seargeant L; Poplawski N
    Am J Med Genet A; 2005 Jul; 136(2):194-7. PubMed ID: 15945070
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Defining the phenotype in congenital disorder of glycosylation due to ALG1 mutations.
    Morava E; Vodopiutz J; Lefeber DJ; Janecke AR; Schmidt WM; Lechner S; Item CB; Sykut-Cegielska J; Adamowicz M; Wierzba J; Zhang ZH; Mihalek I; Stockler S; Bodamer OA; Lehle L; Wevers RA
    Pediatrics; 2012 Oct; 130(4):e1034-9. PubMed ID: 22966035
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A new intronic mutation in the DPM1 gene is associated with a milder form of CDG Ie in two French siblings.
    Dancourt J; Vuillaumier-Barrot S; de Baulny HO; Sfaello I; Barnier A; le Bizec C; Dupre T; Durand G; Seta N; Moore SE
    Pediatr Res; 2006 Jun; 59(6):835-9. PubMed ID: 16641202
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nonimmune hydrops fetalis and congenital disorders of glycosylation: A systematic literature review.
    Makhamreh MM; Cottingham N; Ferreira CR; Berger S; Al-Kouatly HB
    J Inherit Metab Dis; 2020 Mar; 43(2):223-233. PubMed ID: 31420886
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gene identification in the congenital disorders of glycosylation type I by whole-exome sequencing.
    Timal S; Hoischen A; Lehle L; Adamowicz M; Huijben K; Sykut-Cegielska J; Paprocka J; Jamroz E; van Spronsen FJ; Körner C; Gilissen C; Rodenburg RJ; Eidhof I; Van den Heuvel L; Thiel C; Wevers RA; Morava E; Veltman J; Lefeber DJ
    Hum Mol Genet; 2012 Oct; 21(19):4151-61. PubMed ID: 22492991
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification and functional analysis of a defect in the human ALG9 gene: definition of congenital disorder of glycosylation type IL.
    Frank CG; Grubenmann CE; Eyaid W; Berger EG; Aebi M; Hennet T
    Am J Hum Genet; 2004 Jul; 75(1):146-50. PubMed ID: 15148656
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expanding the Molecular and Clinical Phenotype of SSR4-CDG.
    Ng BG; Raymond K; Kircher M; Buckingham KJ; Wood T; Shendure J; Nickerson DA; Bamshad MJ; ; Wong JT; Monteiro FP; Graham BH; Jackson S; Sparkes R; Scheuerle AE; Cathey S; Kok F; Gibson JB; Freeze HH
    Hum Mutat; 2015 Nov; 36(11):1048-51. PubMed ID: 26264460
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Congenital defects of glycosylation: Novel presentations with mainly neurological involvement and variable dysmorphic features.
    İnci A; Cengiz B; Biberoğlu G; Okur İ; Arhan E; Öner AY; Kasapkara ÇS; Küçükçongar A; Tümer L; Ezgu F
    Am J Med Genet A; 2021 Sep; 185(9):2739-2747. PubMed ID: 33960646
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bosch-Boonstra-Schaaf optic atrophy syndrome (BBSOAS) initially diagnosed as ALG6-CDG: Functional evidence for benignity of the ALG6 c.391T>C (p.Tyr131His) variant and further expanding the BBSOAS phenotype.
    Starosta RT; Tarnowski J; Vairo FPE; Raymond K; Preston G; Morava E
    Eur J Med Genet; 2020 Jul; 63(7):103941. PubMed ID: 32407885
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lethal COG6-CDG in neonatal patient with arachnodactyly, joint contractures, and skin manifestations: Founder mutation in the Southeastern European population?
    Ververi A; Stathopoulou T; Kontou A; Farini M; Vlahou G; Demiris N; Sarafidis K
    Pediatr Dermatol; 2022 Mar; 39(2):314-315. PubMed ID: 35048409
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A family with floppy neonates with severe respiratory insufficiency: A lethal phenotype of RFT1-CDG due to a novel mutation.
    Abiramalatha T; Arunachal G; Muthusamy K; Thomas N
    Eur J Med Genet; 2019 Apr; 62(4):248-253. PubMed ID: 30071302
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ALG1-CDG: Clinical and Molecular Characterization of 39 Unreported Patients.
    Ng BG; Shiryaev SA; Rymen D; Eklund EA; Raymond K; Kircher M; Abdenur JE; Alehan F; Midro AT; Bamshad MJ; Barone R; Berry GT; Brumbaugh JE; Buckingham KJ; Clarkson K; Cole FS; O'Connor S; Cooper GM; Van Coster R; Demmer LA; Diogo L; Fay AJ; Ficicioglu C; Fiumara A; Gahl WA; Ganetzky R; Goel H; Harshman LA; He M; Jaeken J; James PM; Katz D; Keldermans L; Kibaek M; Kornberg AJ; Lachlan K; Lam C; Yaplito-Lee J; Nickerson DA; Peters HL; Race V; Régal L; Rush JS; Rutledge SL; Shendure J; Souche E; Sparks SE; Trapane P; Sanchez-Valle A; Vilain E; Vøllo A; Waechter CJ; Wang RY; Wolfe LA; Wong DA; Wood T; Yang AC; ; Matthijs G; Freeze HH
    Hum Mutat; 2016 Jul; 37(7):653-60. PubMed ID: 26931382
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Deficiency of dolichol-phosphate-mannose synthase-1 causes congenital disorder of glycosylation type Ie.
    Imbach T; Schenk B; Schollen E; Burda P; Stutz A; Grunewald S; Bailie NM; King MD; Jaeken J; Matthijs G; Berger EG; Aebi M; Hennet T
    J Clin Invest; 2000 Jan; 105(2):233-9. PubMed ID: 10642602
    [TBL] [Abstract][Full Text] [Related]  

  • 59. ALG11-CDG: novel variant and review of the literature.
    Erdal AE; Ceylan AC; Gücüyener K; Öktem RM; Kıreker Köylü O; Kasapkara ÇS
    J Pediatr Endocrinol Metab; 2023 Apr; 36(4):409-413. PubMed ID: 36843332
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of intercellular cell adhesion molecule 1 (ICAM-1) as a hypoglycosylation marker in congenital disorders of glycosylation cells.
    He P; Ng BG; Losfeld ME; Zhu W; Freeze HH
    J Biol Chem; 2012 May; 287(22):18210-7. PubMed ID: 22496445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.